Effect of vitamin D therapy on bone mineral density in patients with diabetic nephropathy; a randomized, double-blind placebo controlled clinical trial
Authors:
- 19 January 2021
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 20 (1) , 229-235
Abstract
Purpose Diabetes compromises bone strength resulting increased risk of osteoporosis. Objective of this study was to determine the effect of vitamin D given to patients with early diabetic renal disease on BMD and BMC. Methods Patients with diabetic nephropathy were recruited. Treatment group received 50,000 IU of vitamin D3 intramuscularly and the control group was given an equal volume of distilled water (0.25 mL) monthly for six months. Baseline BMD, BMC in the total body, lumbar spine and proximal femur were measured by DXA. After six months measurements were repeated. When trial period was over, a randomly selected subgroup of patients (25 from each group) was followed up for further six-months and measurements were repeated. Results Selected patients were randomly assigned to two groups. After six months, the treatment group total body BMD, total body BMC and BMDs of spine, femoral neck and total hip regions increased by 2.0%, 2.2%, 1.8%, 2.1% and 2.6% (P < 0.05 for all within-group differences), respectively. In the Control group, BMD or BMC of any region mentioned above did not change significantly during the initial 6 months (P < 0.05 for the between-groups differences). After 6 months of stopping treatment, a statistically significant reduction of total BMD and BMC was observed in the treatment group (P = 0.009). Conclusion This study showed that treatment with high dose vitamin D significantly influences total body BMC, total body BMD, BMDs of spine, femoral neck and hip among patients with diabetic nephropathy.Keywords
Funding Information
- UGC grant Sri Lanka (UGC/ICD/CRF/2009/2/24)
This publication has 24 references indexed in Scilit:
- The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis studyBMC Musculoskeletal Disorders, 2013
- Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complicationsJournal of Diabetes and its Complications, 2011
- Efficacy of vitamin D 3 supplementation in preventing fractures in elderly women: A meta-analysisCurrent Medical Research and Opinion, 2010
- Vitamin D and Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Effect of Depot Oral Cholecalciferol Treatment on Secondary Hyperparathyroidism in Stage 3 and Stage 4 Chronic Kidney Diseases PatientsRenal Failure, 2008
- Bisphosphonates in the renal patientNephrology Dialysis Transplantation, 2007
- Improved Renal Allograft Survival with Vitamin D Receptor PolymorphismRenal Failure, 2007
- Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical TrialsJournal of Bone and Mineral Research, 2005
- Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam studyBone, 1996
- Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and CalcitoninNew England Journal of Medicine, 1993